Derivation of AZD5335, a Novel FRα-Targeted TOP1i-Loaded ADC, for the Treatment of FRα-Expressing Cancers
AZD5335 的衍生化，一种新型的 FRα 靶向 TOP1i 负载抗体偶联药物 (ADC)，用于治疗表达 FRα 的癌症
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-25-1749
Zoeller, Jason J; Tammali, Ravinder; Dodd, Roger B; Patel, Neki V; Andoni, Alma; Bisha, Ina; Cronin, Shane; De Almeida, Ana; Lee, Nancy; Meekin, John H 3rd; Tilmont, Isabella; Gasper, Diana; Lan, Lingyun; Cox, Megan; Thomas, Tima; Ward, Christopher; Chesebrough, Jon; Anderton, Judith; Neal, Frances; Zenonos, Zenon; Shandilya, Harini; Chooi, K Phin; Pugh, Kathryn; Saleh, Ali; Wang, Jixin; Mitchell, Pat; Naseer, Humaira; Beaumont, Kevin; Hood, John; Myers, Claire; Christ, Simon; Dino, Iris; Guza, Xhenifer; Falck, Tillmann; Lehmann, Michael; Sargeant, Rebecca; Godfrey, Lisa; Recolin, Benedicte; Brier, Tim; Turner, Simon; Rosfjord, Edward; Fraenkel, Paula G; Cosulich, Sabina; Gymnopoulos, Marco; Hurt, Elaine; Sapra, Puja
